RANI
Rani Therapeutics Holdings Inc
NASDAQ: RANI · HEALTHCARE · BIOTECHNOLOGY
$0.94
+5.87% today
Updated 2026-05-01
Market cap
$108.42M
P/E ratio
—
P/S ratio
66.39x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Rani Therapeutics Holdings Inc (RANI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-26.27M | $-14.96M | $-32.24M | $-46.52M | $-51.24M | $-35.50M | $-18.71M |
| Capital expenditures | $1.58M | $1.20M | $506000.00 | $1.62M | $1.23M | $268000.00 | $88000.00 |
| Depreciation | $564000.00 | $589000.00 | $497000.00 | $548000.00 | $822000.00 | $1.03M | — |
| Stock-based comp | — | $0.00 | $22.59M | $15.78M | $19.01M | $16.03M | $11.80M |
| Free cash flow | $-27.85M | $-16.16M | $-32.75M | $-48.13M | $-52.47M | $-35.76M | $-18.80M |
| Investing cash flow | $-1.53M | $-1.20M | $-506000.00 | $-72.44M | $29.86M | $19.81M | — |
| Financing cash flow | $852000.00 | $72.68M | $77.15M | $29.00M | $233000.00 | $13.59M | — |
| Dividends paid | — | — | — | $29.63M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-89.95M | — | — | — |